Home
Company
Team
Technology
TARTIS rationale
TARTIS disease targets
Pipeline
OT-82
News
Home
Company
Team
Technology
TARTIS rationale
TARTIS disease targets
Pipeline
OT-82
News
News
The Innovation Center started conversion of a vacant space adjacent to OncoTartis facilities into biological laboratories. Project completion is expected in March 2014.
ira.turovets@gmail.com
2016-09-30T18:05:39+00:00
November 19th, 2013
|
OncoTartis relocates to the Innovation Center at Buffalo Niagara Medical Campus. Company’s laboratories and offices occupy 3,000 square feet at 640 Ellicott Street, Buffalo, New York.
ira.turovets@gmail.com
2016-09-30T18:06:06+00:00
February 27th, 2013
|
OncoTartis, Inc. raised $6.4 million in a Series A financing and started its operations in Buffalo, NY.
ira.turovets@gmail.com
2016-09-30T18:06:40+00:00
February 17th, 2011
|
Previous
1
2